The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gemtuzumab Ozogamicin Drugs-Global Market Insights and Sales Trends 2025
Synopsis
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
The global Gemtuzumab Ozogamicin Drugs market size is expected to reach US$ 179.5 million by 2029, growing at a CAGR of -2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gemtuzumab Ozogamicin Drugs in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Gemtuzumab Ozogamicin Drugs market. 5mg/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4.5mg/Vial segment is estimated at % CAGR for the next seven-year period.
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gemtuzumab Ozogamicin Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gemtuzumab Ozogamicin Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gemtuzumab Ozogamicin Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gemtuzumab Ozogamicin Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gemtuzumab Ozogamicin Drugs covered in this report include Pfizer. etc.
The global Gemtuzumab Ozogamicin Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Global Gemtuzumab Ozogamicin Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gemtuzumab Ozogamicin Drugs market, Segment by Type:
5mg/Vial
4.5mg/Vial
Global Gemtuzumab Ozogamicin Drugs market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gemtuzumab Ozogamicin Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gemtuzumab Ozogamicin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
The global Gemtuzumab Ozogamicin Drugs market size is expected to reach US$ 179.5 million by 2029, growing at a CAGR of -2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gemtuzumab Ozogamicin Drugs in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Gemtuzumab Ozogamicin Drugs market. 5mg/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4.5mg/Vial segment is estimated at % CAGR for the next seven-year period.
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gemtuzumab Ozogamicin Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gemtuzumab Ozogamicin Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gemtuzumab Ozogamicin Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gemtuzumab Ozogamicin Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gemtuzumab Ozogamicin Drugs covered in this report include Pfizer. etc.
The global Gemtuzumab Ozogamicin Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Global Gemtuzumab Ozogamicin Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gemtuzumab Ozogamicin Drugs market, Segment by Type:
5mg/Vial
4.5mg/Vial
Global Gemtuzumab Ozogamicin Drugs market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gemtuzumab Ozogamicin Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gemtuzumab Ozogamicin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Gemtuzumab Ozogamicin Drugs Market Overview
1.1 Gemtuzumab Ozogamicin Drugs Product Overview
1.2 Gemtuzumab Ozogamicin Drugs Market Segment by Type
1.2.1 5mg/Vial
1.2.2 4.5mg/Vial
1.3 Global Gemtuzumab Ozogamicin Drugs Market Size by Type
1.3.1 Global Gemtuzumab Ozogamicin Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Gemtuzumab Ozogamicin Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gemtuzumab Ozogamicin Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gemtuzumab Ozogamicin Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gemtuzumab Ozogamicin Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gemtuzumab Ozogamicin Drugs Sales Breakdown by Type (2018-2023)
2 Global Gemtuzumab Ozogamicin Drugs Market Competition by Company
2.1 Global Top Players by Gemtuzumab Ozogamicin Drugs Sales (2018-2023)
2.2 Global Top Players by Gemtuzumab Ozogamicin Drugs Revenue (2018-2023)
2.3 Global Top Players by Gemtuzumab Ozogamicin Drugs Price (2018-2023)
2.4 Global Top Manufacturers Gemtuzumab Ozogamicin Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gemtuzumab Ozogamicin Drugs Market Competitive Situation and Trends
2.5.1 Gemtuzumab Ozogamicin Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gemtuzumab Ozogamicin Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gemtuzumab Ozogamicin Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Gemtuzumab Ozogamicin Drugs Market
2.8 Key Manufacturers Gemtuzumab Ozogamicin Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gemtuzumab Ozogamicin Drugs Status and Outlook by Region
3.1 Global Gemtuzumab Ozogamicin Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gemtuzumab Ozogamicin Drugs Historic Market Size by Region
3.2.1 Global Gemtuzumab Ozogamicin Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Gemtuzumab Ozogamicin Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Gemtuzumab Ozogamicin Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Region
3.3.1 Global Gemtuzumab Ozogamicin Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Gemtuzumab Ozogamicin Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Gemtuzumab Ozogamicin Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gemtuzumab Ozogamicin Drugs by Application
4.1 Gemtuzumab Ozogamicin Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Gemtuzumab Ozogamicin Drugs Market Size by Application
4.2.1 Global Gemtuzumab Ozogamicin Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Gemtuzumab Ozogamicin Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gemtuzumab Ozogamicin Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gemtuzumab Ozogamicin Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gemtuzumab Ozogamicin Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gemtuzumab Ozogamicin Drugs Sales Breakdown by Application (2018-2023)
5 North America Gemtuzumab Ozogamicin Drugs by Country
5.1 North America Gemtuzumab Ozogamicin Drugs Historic Market Size by Country
5.1.1 North America Gemtuzumab Ozogamicin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2018-2023)
5.2 North America Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Country
5.2.1 North America Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2024-2029)
6 Europe Gemtuzumab Ozogamicin Drugs by Country
6.1 Europe Gemtuzumab Ozogamicin Drugs Historic Market Size by Country
6.1.1 Europe Gemtuzumab Ozogamicin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2018-2023)
6.2 Europe Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Country
6.2.1 Europe Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Gemtuzumab Ozogamicin Drugs by Region
7.1 Asia-Pacific Gemtuzumab Ozogamicin Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Gemtuzumab Ozogamicin Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales in Value by Region (2024-2029)
8 Latin America Gemtuzumab Ozogamicin Drugs by Country
8.1 Latin America Gemtuzumab Ozogamicin Drugs Historic Market Size by Country
8.1.1 Latin America Gemtuzumab Ozogamicin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Country
8.2.1 Latin America Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Gemtuzumab Ozogamicin Drugs by Country
9.1 Middle East and Africa Gemtuzumab Ozogamicin Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Gemtuzumab Ozogamicin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gemtuzumab Ozogamicin Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gemtuzumab Ozogamicin Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Gemtuzumab Ozogamicin Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Gemtuzumab Ozogamicin Drugs Products Offered
10.1.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gemtuzumab Ozogamicin Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gemtuzumab Ozogamicin Drugs Industrial Chain Analysis
11.4 Gemtuzumab Ozogamicin Drugs Market Dynamics
11.4.1 Gemtuzumab Ozogamicin Drugs Industry Trends
11.4.2 Gemtuzumab Ozogamicin Drugs Market Drivers
11.4.3 Gemtuzumab Ozogamicin Drugs Market Challenges
11.4.4 Gemtuzumab Ozogamicin Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gemtuzumab Ozogamicin Drugs Distributors
12.3 Gemtuzumab Ozogamicin Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
